NCT05558397View on ClinicalTrials.gov

Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Cancer PainOpioid UseCost AnalysisPalliative CareEpidural RouteMorphine-ropivacaine AssociationQuality of LifeRational Use of Medication
Interventions
DEVICE

Interventional Group (Epidural morphine)

Implantation of an epidural catheter for administration of morphine and ropvacaine

DRUG

Control Group (Oral morphine)

Oral administration of morphine, pregabalin or duloxetin

Trial Locations (1)

37137001

Larissa Helena Lobo Torres Pacheco, Alfenas

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do estado de Minas Gerais

OTHER

lead

Universidade Federal de Alfenas

OTHER

NCT05558397 - Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment | Biotech Hunter | Biotech Hunter